Christopher John Swift
Analyst · Barclays
Tom, it's Chris. The challenge, I'll call it succinctly, is, I mean, if you look at the balance sheet, we have about $165 billion of liabilities that are in runoff in the Life group. So one, it's obvious, just the sheer size and scale. There's not going to be, I'll call it, 1 solution, 1 silver bullet. So the way we're thinking about it right now, I mean, this will be a series of moves over a longer period of time to eventually transfer runoffs, isolate, separate these liabilities. So there isn't going to just be 1 thing. I think I've always said, Tom, and particularly, I know you know, I mean, if you really look at the fundamentals of the U.S. and Japan, they're different. The U.S. block from a relative risk perspective or relative size and its components are fixed and variable, actually, it's a balanced portfolio liabilities. Japan, on the other hand, I think from a shareholder value perspective, is the greatest opportunity we have to manage that in the most accretive way long term. So whether that be a short-term transaction or that would be long-term, just managing the cash flows as effectively as possible, those are the things that we're thinking about and modeling and working very diligently on.
Thomas G. Gallagher - Crédit Suisse AG, Research Division: And Chris, any issues with captive re and whether or not -- I think there's some level of speculation out there that because the way the captive reinsurance is capitalized, the captive reinsure is capitalized, that it would take years and years before you could release capital out of these businesses. Is there any truth to that? Or maybe you can comment on that.